Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Multimodality Treatments in Metastatic Gastric Cancer
| Multimodality Treatments in Metastatic Gastric Cancer |
| Autore | Petrillo Angelica |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 electronic resource (162 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
advanced gastric cancer
precision medicine new drug development gastro-oesophageal cancer mutational concordance exome sequencing formalin fixed paraffin embedded biomarkers gastric cancer metastatic body composition sarcopenia visceral fat area subcutaneous fat area outcome toxicity liver metastasis conversion surgery hepatectomy stage iv gastric cancer immune checkpoint inhibitors Epstein Barr Virus tumor mutational burden microsatellite instability predictive biomarkers CAR T cell therapy vaccines nutritional status metastatic gastric cancer target therapy bone flare stage IV treatment RANK-L liquid biopsy circulating tumor cell cfDNA ctDNA epithelial-mesenchymal transition resistance to treatment HER2-inhibition VEGFR-inhibition immunotherapy response monitoring |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557390503321 |
Petrillo Angelica
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Treatment Strategies and Survival Outcomes in Breast Cancer
| Treatment Strategies and Survival Outcomes in Breast Cancer |
| Autore | Cheung Kwok-Leung |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 electronic resource (264 p.) |
| Soggetto non controllato |
relative survival
young women cancer treatment fulvestrant lapatinib tumor biology antihormone therapy mastectomy aromatase inhibitors chemotherapy serum biomarker cyclin E anthracycline resistance zero-inflated Poisson regression model lymph-node ratio CHEK2 comparative effectiveness breast-conserving therapy taxane sensitivity liquid biopsy HER2 c-erbB2 colorectal cancer infiltrating breast cancer survival exercise characteristics lactate dehydrogenase biomarker breast cancer survivors BRCA disease-free survival PIK3CA metastatic breast cancer cell-free DNA invasive breast cancer radiotherapy Metformin social well-being gene expression contralateral breast cancer basal-like breast cancer LMK-235 Src kinase HER2/neu LKB1 Older women LDH mutation carriers stage IV mammography screening NCDB cMet SEER pertuzumab physical function outcome ribociclib older patients geriatric oncology metastatic overdiagnosis next-generation sequencing abemaciclib Endocrine therapy monitoring metastatic breast cancer breast cancer circulating tumor cells Breast Cancer PALB2 histone deacetylase prognosis physical activity trastuzumab ductal carcinoma in situ contralateral prophylactic mastectomy ERCC1 family history T-DM1 ATM advanced breast cancer incidence palbociclib HDAC5 inhibitors APOBEC3B |
| ISBN | 3-03928-759-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910404084403321 |
|
Cheung Kwok-Leung
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||